Research
Learn about published research as well as leading-edge basic and translational research initiatives from St. Jude laboratories.
Study reveals the neurochemical gatekeeper to learning and the key to unlocking it
St. Jude research uncovers neural secrets behind our capacity to learn
Drug which blocks stress granule formation offers insight into biomolecular condensates
See how G3BP inhibitors represent turning point in RNP granule research
Following the breadcrumbs: Gain-of-function mutation leads researchers to new therapeutic target for pediatric AML
Explore the mechanistic insights behind novel pediatric AML therapeutic target
Exploring the interplay between vaccines and immune system development in infants
Explore new research delving into pediatric immune responses to vaccination
CRISPR kickstarts combination drug discovery for neuroblastoma
A CRISPR screen reveals a potential combination therapy for relapsed neuroblastoma.
Finding the big-TIME players holding back CAR T–cell therapy for high-grade gliomas
Explore how tumor-associated macrophages shape CAR T-cell therapy efficacy in high-grade gliomas.
Ribosome production presents a new therapeutic opportunity against Wilms tumor
Discover how disruption ribosomes creation provides promise for “undruggable” cancers.
Just like the real thing: Synthetic gene expression regulators demonstrate success
See how Aseem Ansari's SynGRs target BET proteins, offering potential for treating diseases like Friedreich’s ataxia and advancing BET domain understanding
St. Jude Research Collaboratives program reaches across institutional boundaries to multiply impact
Learn more about how the St. Jude Research Collaboratives Program is driving scientific breakthroughs.
Consortium on leukemia in children with Down syndrome offers energy and optimism
Leukemia in children with Down syndrome addressed at St. Jude as international consortium meets